Track market-moving stories before they get noisy

MaxLinear (MXL - Free Report) came out with quarterly earnings of $0.35 per share, beating the Zacks Consensus Estimate of $0.33 per share. This compares to earnings of $0.02 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of +6.06%. A quarter ago, it was expected that this chipmaker would post earnings of $0.18 per share when it actually produced earnings of $0.22, delivering a surprise of +22.22%.

Over the last four quarters, the company has surpassed consensus EPS estimates four times.

MaxLinear, which belongs to the Zacks Semiconductor - Analog and Mixed industry, posted revenues of $168.85 million for the quarter ended June 2026, surpassing the Zacks Consensus Estimate by 2.33%. This compares to year-ago revenues of $108.81 million. The company has topped consensus revenue estimates four times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

MaxLinear shares have added about 398% since the beginning of the year versus the S&P 500's gain of 9.6%.

What's Next for MaxLinear?While MaxLinear has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for MaxLinear was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.36 on $171.6 million in revenues for the coming quarter and $1.30 on $651.83 million in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Semiconductor - Analog and Mixed is currently in the top 9% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Another stock from the same industry, ON Semiconductor Corp. (ON - Free Report) , has yet to report results for the quarter ended June 2026. The results are expected to be released on August 3.

This semiconductor components maker is expected to post quarterly earnings of $0.72 per share in its upcoming report, which represents a year-over-year change of +35.9%. The consensus EPS estimate for the quarter has been revised 0.4% higher over the last 30 days to the current level.

ON Semiconductor Corp.'s revenues are expected to be $1.59 billion, up 8% from the year-ago quarter.

Deckers (DECK - Free Report) came out with quarterly earnings of $0.94 per share, beating the Zacks Consensus Estimate of $0.88 per share. This compares to earnings of $0.93 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of +6.82%. A quarter ago, it was expected that this maker of Ugg footwear would post earnings of $0.81 per share when it actually produced earnings of $0.96, delivering a surprise of +18.52%.

Over the last four quarters, the company has surpassed consensus EPS estimates four times.

Deckers, which belongs to the Zacks Retail - Apparel and Shoes industry, posted revenues of $1.02 billion for the quarter ended June 2026, surpassing the Zacks Consensus Estimate by 0.25%. This compares to year-ago revenues of $964.54 million. The company has topped consensus revenue estimates four times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

Deckers shares have lost about 1.2% since the beginning of the year versus the S&P 500's gain of 9.6%.

What's Next for Deckers?While Deckers has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Deckers was favorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #2 (Buy) for the stock. So, the shares are expected to outperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $1.87 on $1.55 billion in revenues for the coming quarter and $7.46 on $5.91 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Retail - Apparel and Shoes is currently in the top 24% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

One other stock from the same industry, Fossil Group (FOSL - Free Report) , is yet to report results for the quarter ended June 2026.

This watch and accessories maker is expected to post quarterly loss of $0.29 per share in its upcoming report, which represents a year-over-year change of -190%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.

Fossil Group's revenues are expected to be $200.3 million, down 9.1% from the year-ago quarter.

Premium Retail’s Stress Test Is Separating Winners From LosersDeckers Outdoor NYSE: DECK reported first-quarter fiscal 2027 revenue above $1 billion for the first time in company history, as growth in its HOKA and UGG brands and continued strength in direct-to-consumer sales helped offset planned wholesale timing shifts.

President and Chief Executive Officer Stefano Caroti said total company revenue rose 5.7% from a year earlier, while diluted earnings per share came in at $0.94. Both metrics were above the company’s expectations for the quarter. Total direct-to-consumer revenue increased 13%, led by a 17% gain at HOKA and a 6% increase at UGG.

Get Deckers Outdoor alerts:

Apparel Earnings Winners and Losers: Ralph Lauren Takes Off“Both HOKA and UGG maintained solid momentum and continued to capture high level of full price consumer demand,” Caroti said. He added that underlying consumer demand remained strong both internationally and in the United States, despite what the company described as a pressured consumer backdrop.

HOKA Growth Led by DTC and Product Innovation HOKA generated first-quarter revenue of $704 million, up 8% from a year earlier. Caroti said the brand’s performance was driven by global direct-to-consumer growth, including continued gains across Europe, China, Japan and the United States.

Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus?Deckers said demand was broad-based across HOKA product families, with strength in established franchises such as Clifton and Bondi as well as newer and updated models. Caroti highlighted Speedgoat 7, Mach 7, Mafate Speed 2 and Skyward products as contributors to demand. He said trail and lifestyle styles together accounted for more than half of global HOKA direct-to-consumer growth in the quarter.

The company also pointed to the early launch of Clifton Pro as an important product milestone. Caroti said the shoe had been in the market for about two weeks and had already prompted some wholesale reorders. He said the Clifton Pro is part of a broader effort to create clearer technology and product architecture within HOKA, including “Glide” products designed for cushioning and “Fly” products focused on responsiveness and speed.

HOKA wholesale revenue increased 3% globally. Management said the wholesale result was in line with expectations and reflected international shipment timing differences compared with unusually early shipments in the prior year. In the U.S., HOKA delivered higher sell-in and stronger full-price sell-through, while EMEA posted what Caroti called “another quarterly record for reorders.”

UGG Advances Year-Round Strategy UGG revenue rose 5% year over year to $278 million, with direct-to-consumer revenue up 6% and wholesale up 5%. Caroti said the brand grew in both the U.S. and international markets, with international growth led by Asia.

Management said UGG’s results reflected progress in its “365” strategy and men’s growth initiatives. The company continued to allocate availability of key classic styles while increasing marketing and product investment in fashion-casual footwear, sneakers and sandals.

Caroti cited demand for the Lowmel franchise, the new Minimel introduction and the Golden Collection, including GoldenGaze silhouettes. He said the men’s business accounted for the largest portion of incremental UGG revenue in the quarter, supported by all-gender products such as Tasman and Lowmel as well as newer men’s products including the Ottosee clog.

In response to an analyst question, Caroti said UGG’s men’s business remains about 15% of revenue, with a goal of reaching 20% or more. He also said the brand is less dependent on cold weather than in the past because of a more diversified offering across sneakers, sandals, mules and other year-round products.

Margins Improve Despite Tariff Headwinds Chief Financial Officer Steve Fasching said total revenue for the quarter was $1.02 billion. Gross margin improved to 56.4%, up 60 basis points from 55.8% a year earlier.

Fasching said the margin improvement was driven by favorable channel mix as direct-to-consumer grew faster than wholesale, favorable product mix and full-price selling, foreign currency benefits and better management of product closeouts. These benefits were partially offset by tariffs.

In the question-and-answer session, Fasching said better management of closeouts contributed about 60 basis points to first-quarter gross margin, while full-price selling together with channel and brand mix contributed about 110 basis points. Foreign exchange added about 40 basis points, while tariffs reduced gross margin by about 150 basis points year over year.

SG&A expense rose 13% to $420 million, reflecting hiring, marketing investments, higher rent related primarily to global HOKA stores, technology spending and foreign currency remeasurement. Deckers ended the quarter with $1.6 billion in cash and equivalents, inventory down 5% year over year to $808 million and no outstanding borrowings.

The company repurchased approximately $338 million of shares during the quarter at an average price of $103.79. As of June 30, 2026, Deckers had about $4.7 billion remaining under its share repurchase authorization.

Guidance Raised on Earnings and Margin Deckers maintained its fiscal 2027 revenue outlook of $5.86 billion to $5.91 billion, representing high-single-digit growth from the prior year. The company still expects HOKA revenue to rise at a low-double-digit rate and UGG revenue to increase at a mid-single-digit rate.

However, Deckers raised its gross margin expectation to slightly better than 56.5%, citing first-quarter outperformance. The company also increased its assumed go-forward tariff rate to 12.5% from 10%. Fasching said Deckers continues to pursue tariff refunds related to an IEEPA ruling but has not included any refund assumptions in its guidance.

Operating margin is now expected to be slightly better than 21.5%, and diluted EPS is projected at $7.35 to $7.50, up $0.05 from the prior outlook. SG&A is still expected to be about 35% of revenue as the company continues investing in growth initiatives.

For the second quarter, Deckers expects consolidated revenue to rise about 5% year over year. Fasching said HOKA is expected to contribute high-single-digit growth, UGG is expected to maintain mid-single-digit growth, and other brands are expected to decline about 50%, primarily due to portfolio streamlining. Second-quarter diluted EPS is expected to range from $1.73 to $1.78.

Management reiterated that growth is expected to accelerate in the second half of the fiscal year, driven primarily by HOKA’s international wholesale and distributor business. Fasching said the timing shift reflects logistics changes rather than a change in demand assumptions.

Management Emphasizes Full-Price Marketplace Throughout the call, Deckers executives emphasized the importance of maintaining a premium, full-price marketplace. Caroti said inventories remain tight and that the company is focused on preserving a “pull model” of demand.

“Our full price sell-through continues to be strong,” Caroti said. “Inventories are tight. Inventories are down 5% for the quarter.”

Fasching said high gross margins support brand credibility and benefit retail partners. He added that Deckers has not assumed a significant change in promotional cadence for the rest of the year.

Caroti said the company remains confident in its fiscal 2027 outlook, citing product innovation, disciplined marketplace execution and continued engagement with HOKA and UGG across channels and geographies.

About Deckers Outdoor (NYSE:DECK)Deckers Outdoor Corporation is a global designer, marketer and distributor of footwear, apparel and accessories. The company's product portfolio includes well‐known brands such as UGG, HOKA, Teva, Sanuk and Koolaburra by UGG, spanning a range of lifestyle, performance and outdoor categories. Deckers leverages a blend of proprietary manufacturing, strategic brand storytelling and direct‐to‐consumer retail to serve both fashion‐focused and performance‐oriented customers.

Founded in 1973 by Doug Otto and Karl F.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].

Should You Invest $1,000 in Deckers Outdoor Right Now?Before you consider Deckers Outdoor, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Deckers Outdoor wasn't on the list.

While Deckers Outdoor currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

For the quarter ended June 2026, Eastern Bankshares, Inc. (EBC - Free Report) reported revenue of $309.5 million, up 26.4% over the same period last year. EPS came in at $0.49, compared to $0.41 in the year-ago quarter.

The reported revenue represents a surprise of +1.7% over the Zacks Consensus Estimate of $304.32 million. With the consensus EPS estimate being $0.46, the EPS surprise was +6.52%.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Eastern Bankshares performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

Efficiency ratio (GAAP): 54.3% versus the six-analyst average estimate of 53%.Net interest margin (FTE): 3.7% versus 3.7% estimated by six analysts on average.Average Balance - Total interest-earning assets: $28.3 billion versus the five-analyst average estimate of $28.39 billion.Total non-performing assets: $109.4 million versus $137.7 million estimated by three analysts on average.Total non-performing loans: $109.4 million versus the two-analyst average estimate of $137.7 million.Net Interest Income: $251.9 million versus the six-analyst average estimate of $255.62 million.Total Noninterest Income: $57.6 million compared to the $48.38 million average estimate based on six analysts.Investment advisory fees: $19.7 million versus the five-analyst average estimate of $19.12 million.Miscellaneous income and fees: $9.8 million compared to the $7.89 million average estimate based on four analysts.Net Interest Income (FTE): $258.2 million versus $258.99 million estimated by four analysts on average.Service charges on deposit accounts: $10 million versus $10.29 million estimated by four analysts on average.Interest rate swap income: $2 million versus $1.09 million estimated by four analysts on average.View all Key Company Metrics for Eastern Bankshares here>>>

Shares of Eastern Bankshares have returned +5.3% over the past month versus the Zacks S&P 500 composite's +0.4% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Symbotic Inc. (SYM - Free Report) ended the recent trading session at $40.57, demonstrating a -4.45% change from the preceding day's closing price. The stock fell short of the S&P 500, which registered a loss of 1.21% for the day. On the other hand, the Dow registered a loss of 0.97%, and the technology-centric Nasdaq decreased by 2.15%.

Heading into today, shares of the company had gained 7.68% over the past month, outpacing the Business Services sector's gain of 3.63% and the S&P 500's gain of 0.42%.

The upcoming earnings release of Symbotic Inc. will be of great interest to investors. The company's earnings report is expected on August 5, 2026. The company is predicted to post an EPS of $0.12, indicating a 340% growth compared to the equivalent quarter last year. Our most recent consensus estimate is calling for quarterly revenue of $714.76 million, up 20.71% from the year-ago period.

In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of $0.5 per share and a revenue of $2.79 billion, indicating changes of -72.53% and +24.13%, respectively, from the former year.

Investors should also pay attention to any latest changes in analyst estimates for Symbotic Inc. Recent revisions tend to reflect the latest near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the business outlook.

Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.

The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. The Zacks Consensus EPS estimate remained stagnant within the past month. Symbotic Inc. currently has a Zacks Rank of #3 (Hold).

Valuation is also important, so investors should note that Symbotic Inc. has a Forward P/E ratio of 85.35 right now. This indicates a premium in contrast to its industry's Forward P/E of 16.57.

We can additionally observe that SYM currently boasts a PEG ratio of 2.84. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. Technology Services stocks are, on average, holding a PEG ratio of 1.44 based on yesterday's closing prices.

The Technology Services industry is part of the Business Services sector. This industry, currently bearing a Zacks Industry Rank of 91, finds itself in the top 37% echelons of all 250+ industries.

The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.

Glacier Bancorp (GBCI - Free Report) came out with quarterly earnings of $0.76 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.45 per share a year ago. These figures are adjusted for non-recurring items.

A quarter ago, it was expected that this bank holding company would post earnings of $0.67 per share when it actually produced earnings of $0.7, delivering a surprise of +4.48%.

Over the last four quarters, the company has surpassed consensus EPS estimates two times.

Glacier Bancorp, which belongs to the Zacks Banks - West industry, posted revenues of $317.53 million for the quarter ended June 2026, missing the Zacks Consensus Estimate by 2.06%. This compares to year-ago revenues of $240.56 million. The company has topped consensus revenue estimates two times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

Glacier Bancorp shares have added about 16.2% since the beginning of the year versus the S&P 500's gain of 9.6%.

What's Next for Glacier Bancorp?While Glacier Bancorp has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Glacier Bancorp was favorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #2 (Buy) for the stock. So, the shares are expected to outperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.83 on $336 million in revenues for the coming quarter and $3.16 on $1.32 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Banks - West is currently in the top 20% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

One other stock from the same industry, Bank of Hawaii (BOH - Free Report) , is yet to report results for the quarter ended June 2026. The results are expected to be released on July 27.

This bank holding company is expected to post quarterly earnings of $1.46 per share in its upcoming report, which represents a year-over-year change of +37.7%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.

Bank of Hawaii's revenues are expected to be $198.31 million, up 13.7% from the year-ago quarter.

In the latest close session, Abercrombie & Fitch (ANF - Free Report) was down 5.36% at $90.89. The stock fell short of the S&P 500, which registered a loss of 1.21% for the day. Elsewhere, the Dow lost 0.97%, while the tech-heavy Nasdaq lost 2.15%.

The teen clothing retailer's stock has climbed by 8.12% in the past month, exceeding the Retail-Wholesale sector's gain of 2.27% and the S&P 500's gain of 0.42%.

Market participants will be closely following the financial results of Abercrombie & Fitch in its upcoming release. The company is expected to report EPS of $1.9, down 18.1% from the prior-year quarter. Our most recent consensus estimate is calling for quarterly revenue of $1.24 billion, up 2.76% from the year-ago period.

ANF's full-year Zacks Consensus Estimates are calling for earnings of $10.46 per share and revenue of $5.43 billion. These results would represent year-over-year changes of +6.09% and +3.18%, respectively.

Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Abercrombie & Fitch. These revisions typically reflect the latest short-term business trends, which can change frequently. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.

Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.

The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed a 1.43% decrease. Abercrombie & Fitch is holding a Zacks Rank of #3 (Hold) right now.

Looking at valuation, Abercrombie & Fitch is presently trading at a Forward P/E ratio of 9.18. Its industry sports an average Forward P/E of 16.08, so one might conclude that Abercrombie & Fitch is trading at a discount comparatively.

The Retail - Apparel and Shoes industry is part of the Retail-Wholesale sector. This industry currently has a Zacks Industry Rank of 58, which puts it in the top 24% of all 250+ industries.

The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

To follow ANF in the coming trading sessions, be sure to utilize Zacks.com.

RingCentral (RNG - Free Report) came out with quarterly earnings of $1.22 per share, beating the Zacks Consensus Estimate of $1.17 per share. This compares to earnings of $1.06 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of +4.27%. A quarter ago, it was expected that this cloud-based phone system provider for small businesses would post earnings of $1.17 per share when it actually produced earnings of $1.2, delivering a surprise of +2.56%.

Over the last four quarters, the company has surpassed consensus EPS estimates four times.

RingCentral, which belongs to the Zacks Internet - Software and Services industry, posted revenues of $657.01 million for the quarter ended June 2026, surpassing the Zacks Consensus Estimate by 1.03%. This compares to year-ago revenues of $620.4 million. The company has topped consensus revenue estimates four times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

RingCentral shares have added about 30.4% since the beginning of the year versus the S&P 500's gain of 9.6%.

What's Next for RingCentral?While RingCentral has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for RingCentral was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $1.25 on $662.96 million in revenues for the coming quarter and $4.91 on $2.63 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Internet - Software and Services is currently in the top 28% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Sabre (SABR - Free Report) , another stock in the same industry, has yet to report results for the quarter ended June 2026.

This provider of technology services to the travel industry is expected to post quarterly loss of $0.06 per share in its upcoming report, which represents a year-over-year change of -200%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.

Sabre's revenues are expected to be $695.43 million, up 1.2% from the year-ago quarter.

Ralph Lauren (RL - Free Report) closed at $371.69 in the latest trading session, marking a -3.99% move from the prior day. This move lagged the S&P 500's daily loss of 1.21%. On the other hand, the Dow registered a loss of 0.97%, and the technology-centric Nasdaq decreased by 2.15%.

Shares of the upscale clothing company witnessed a loss of 6.54% over the previous month, trailing the performance of the Consumer Discretionary sector with its loss of 0.92%, and the S&P 500's gain of 0.42%.

Market participants will be closely following the financial results of Ralph Lauren in its upcoming release. The company plans to announce its earnings on August 6, 2026. The company is forecasted to report an EPS of $4.26, showcasing a 13% upward movement from the corresponding quarter of the prior year. Alongside, our most recent consensus estimate is anticipating revenue of $1.86 billion, indicating a 8.42% upward movement from the same quarter last year.

For the full year, the Zacks Consensus Estimates are projecting earnings of $18.33 per share and revenue of $8.66 billion, which would represent changes of +10.49% and +6.73%, respectively, from the prior year.

Investors should also take note of any recent adjustments to analyst estimates for Ralph Lauren. These recent revisions tend to reflect the evolving nature of short-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the business outlook.

Based on our research, we believe these estimate revisions are directly related to near-term stock moves. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.

The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed a 0.02% decrease. Ralph Lauren presently features a Zacks Rank of #3 (Hold).

In terms of valuation, Ralph Lauren is currently trading at a Forward P/E ratio of 21.12. Its industry sports an average Forward P/E of 16.35, so one might conclude that Ralph Lauren is trading at a premium comparatively.

Meanwhile, RL's PEG ratio is currently 1.92. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. The average PEG ratio for the Textile - Apparel industry stood at 2.26 at the close of the market yesterday.

The Textile - Apparel industry is part of the Consumer Discretionary sector. This industry, currently bearing a Zacks Industry Rank of 182, finds itself in the bottom 27% echelons of all 250+ industries.

The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.

On July 23, 2026, HubSpot Inc (HUBS) shares fell 7.3% to a current price of $190.01. This decline is notable within the context of its 52-week range, where the

In Brief

Posted:

3:40 PM PDT · July 23, 2026

Image Credits:Bridget Bennett / Bloomberg / Getty Images Mobileye founder and CEO Amnon Shashua plans to step down from the top leadership post after nearly three decades, just as the company pushes into robotaxis and humanoid robots.

Shashua will remain CEO until Mobileye hires a replacement, according to a regulatory filing Thursday.

Mobileye got its start making computer vision chips based on Shashua’s academic research at Hebrew University in Israel, and grew into a major supplier of the chips that power automotive safety and driver-assistance features. It had the largest IPO in Israel’s history, was acquired in 2017 by Intel for $15.3 billion, then spun back out as a publicly traded company in 2022, though Intel remains its largest shareholder.

Under Shashua, Mobileye also moved beyond selling chips to automakers and began building its own systems that handle autonomous driving, which it now supplies to Volkswagen and its MOIA subsidiary.

In January, the company acquired Shashua’s humanoid robotics startup Mentee Robotics for $900 million, which Shashua called part of “Mobileye 3.0,” the next phase of the business focused on robotics and automotive AI.

Mobileye also said in June it would expand beyond its supplier status to launch its own robotaxi service in a U.S. city in 2027.

Topics

Subscribe for the industry’s biggest tech news

Latest in Transportation

Bitcoin mining pools have traditionally operated on a simple bargain: you give us your hashpower and your personal information, and we give you a dashboard. Ocean Mining just decided that second part is unnecessary.

The decentralized mining pool launched Portal on July 22 at the Mining Disrupt 2026 conference in Miami, introducing what it calls a permissionless, end-to-end encrypted dashboard for miners. The tool requires no account creation, no email, and no KYC verification. All a miner needs is a Bitcoin address.

What Portal actually does The dashboard lets miners aggregate multiple Bitcoin addresses into a single view, complete with site and worker statistics, payout tracking in both Bitcoin and fiat, and advanced reporting tools.

Advertisement

Ocean President Mark Artymko introduced the tool live on stage at the Miami Airport Convention Center. The core pitch is straightforward: miners should be able to monitor their operations without surrendering data sovereignty to the pool itself.

The privacy layer runs on something Ocean calls its Sub-space Locker, a locally executed encryption method. In English: your data gets encrypted on your own device before it ever touches Ocean’s infrastructure. The pool literally cannot see what you’re looking at.

Portal also includes human-readable labels for addresses.

Ocean’s broader play for miner sovereignty The pool, developed by parent company Mummolin, Inc., has built its identity around non-custodial mining and transparent payouts. Its leadership team includes Luke Dashjr as Chairman and CTO and Jason Hughes as VP of Engineering.

The pool currently operates at approximately 28.44 Eh/s of hashrate.

On the compliance front, Ocean has acquired both SOC 2 Type 1 and SOC 1 Type 1 security attestations.

Disclosure: This article was edited by Editorial Team. For more information on how we create and review content, see our Editorial Policy.

Why Wall Street Is Backing These 3 Comeback StocksSummit Therapeutics NASDAQ: SMMT executives used the company’s latest earnings call to emphasize updated survival data for ivonescimab, outline the timing of key late-stage trial readouts and detail the company’s cash position as it prepares for a potential U.S. regulatory decision later this year.

Chairman and Co-Chief Executive Officer Bob Duggan said Summit remains focused on ivonescimab, its PD-1/VEGF bispecific antibody and lead investigational asset. Duggan said ivonescimab has produced positive data in four Phase III clinical studies to date, leading to two approvals in China, with one additional filing under review there. He said 15 Phase III trials are ongoing or have read out across multiple tumor types, and that Summit and partner Akeso have initiated 52 clinical trials evaluating the drug.

Get Summit Therapeutics alerts:

MarketBeat Week in Review – 11/4 - 11/8Duggan also said more than 4,000 patients have been dosed with ivonescimab in Summit- or Akeso-sponsored clinical trials globally, while more than 70,000 patients have received the drug commercially in China.

Updated HARMONi Data Submitted to FDA President and Co-Chief Executive Officer Dr. Maky Zanganeh highlighted an updated overall survival analysis from the global Phase III HARMONi trial, which evaluated ivonescimab plus chemotherapy versus chemotherapy alone in patients with EGFR-mutated non-small cell lung cancer after TKI therapy.

Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?Zanganeh said the latest analysis, with a June 2026 data cutoff, showed Western patients had reached a median follow-up of more than 23 months, while Asian patients remained at a median follow-up of 33 months. The company reported an overall survival hazard ratio of 0.76 in both the total population and the Western regional data.

“The hazard ratio for Western patients has improved with more follow-up time,” Zanganeh said, adding that the Western results are now consistent with the magnitude of overall survival benefit seen in Asian patients, who had longer follow-up at the primary analysis.

Summit said no new safety signals were observed in the latest data cut, and that the safety profile remained acceptable and manageable, consistent with previous Phase III results of ivonescimab plus chemotherapy.

Zanganeh said Summit has made the updated results available to the U.S. Food and Drug Administration. The company’s biologics license application for ivonescimab plus chemotherapy in the EGFR-mutated non-small cell lung cancer post-TKI setting remains under FDA review, with a target PDUFA date of Nov. 14. Zanganeh noted that the FDA has previously said a statistically significant overall survival benefit is necessary to support marketing authorization in this setting.

Key Trial Timelines Remain in Focus Summit also provided updates on several global Phase III studies. HARMONi-3 is evaluating ivonescimab plus chemotherapy against pembrolizumab plus chemotherapy in first-line metastatic non-small cell lung cancer in both squamous and non-squamous histologies, which will be analyzed separately.

Zanganeh said enrollment has been completed in both cohorts. Summit expects to reach the number of events needed for a progression-free survival analysis in the squamous cohort in the second half of this year, along with an early interim look at overall survival. The company expects a separate overall survival interim analysis in the first half of 2027. For the non-squamous cohort, Summit expects to reach the number of events for a progression-free survival analysis in the first half of 2027.

In the question-and-answer session, Chief Business and Strategy Officer Dave Gancarz said the HARMONi-3 squamous PFS timing is likely “towards the middle to back end of 2026,” rather than in the near term. He said the first-half 2027 overall survival analysis should have median follow-up generally consistent with the HARMONi-6 analysis and the updated Western patient data from HARMONi.

Summit said HARMONi-7, which compares ivonescimab monotherapy against pembrolizumab monotherapy in first-line non-small cell lung cancer with high PD-L1 expression, continues to enroll. HARMONi-GI3 is evaluating ivonescimab plus chemotherapy versus bevacizumab plus chemotherapy as first-line therapy in unresectable colorectal cancer.

Combination Collaborations Expand Development Plans Zanganeh also reviewed Summit’s collaborations with Revolution Medicines, GSK and Arcus Biosciences. The Revolution Medicines collaboration began enrolling in the first quarter and is evaluating ivonescimab with three novel RAS inhibitors across solid tumor settings including pancreatic, colorectal and non-small cell lung cancers.

Summit expects its GSK collaboration, which will evaluate ivonescimab with GSK’s B7-H3 antibody-drug conjugate in multiple solid tumors, to enroll its first patient later this quarter. The company also announced a collaboration with Arcus to evaluate ivonescimab with Arcus’ HIF-2α inhibitor casdatifan in first-line metastatic clear cell renal cell carcinoma. Summit expects initial data from that collaboration by mid-next year.

The company also pointed to ILLUMINE, a Phase III head and neck cancer study sponsored by European cooperative group GORTEC, which is enrolling in Europe and is expected to begin in China later this year.

Cash Position Rises, Expenses Increase Chief Operating Officer and Chief Financial Officer Manmeet Soni said Summit ended the second quarter of 2026 with $690.7 million in cash, up from $598.7 million at the end of the first quarter. Soni attributed the $92 million increase primarily to $231 million raised through the company’s at-the-market facility, partially offset by approximately $140 million used in operating activities during the quarter.

Soni said Summit filed a prospectus supplement for a new ATM facility of up to $380 million to provide additional financing flexibility. He also said the company currently has no debt on its balance sheet.

Total GAAP operating expenses were $220.5 million in the second quarter, compared with $195.2 million in the first quarter. Non-GAAP operating expenses, which exclude stock-based compensation, were $151.8 million, compared with $122.4 million in the prior quarter. Soni said the increase was primarily driven by higher research and development expenses related to clinical trial costs for HARMONi-GI3, HARMONi-3 and HARMONi-7.

Commercial Preparation Underway In response to an analyst question, Soni said Summit is preparing for a possible U.S. commercial launch ahead of the Nov. 14 PDUFA date. He said the company has hired its commercial leadership team, market access staff and marketing personnel, while field force hiring would typically occur closer to the regulatory date. Gancarz added that the company has also ramped up medical science liaisons.

Duggan closed the call by reiterating management’s confidence in ivonescimab. “We know that ivonescimab works,” he said. “The question I leave you with is, what if ivonescimab works really well?”

About Summit Therapeutics (NASDAQ:SMMT)Summit Therapeutics plc is a clinical‐stage biotechnology company dedicated to the discovery and development of precision medicines for serious and life‐threatening diseases. The company applies a targeted approach to drug design, focusing on novel mechanisms of action that differentiate its candidates from existing therapies.

Summit's lead asset, ridinilazole (formerly SMT19969), is being developed to treat Clostridioides difficile infections and has received both Fast Track and Qualified Infectious Disease Product designations from the U.S.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].

Should You Invest $1,000 in Summit Therapeutics Right Now?Before you consider Summit Therapeutics, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Summit Therapeutics wasn't on the list.

While Summit Therapeutics currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Cava Group (CAVA - Free Report) ended the recent trading session at $63.21, demonstrating a +1.38% change from the preceding day's closing price. This move outpaced the S&P 500's daily loss of 1.21%. Elsewhere, the Dow saw a downswing of 0.97%, while the tech-heavy Nasdaq depreciated by 2.15%.

Shares of the Mediterranean restaurant chain witnessed a loss of 24.19% over the previous month, trailing the performance of the Retail-Wholesale sector with its gain of 2.27%, and the S&P 500's gain of 0.42%.

The investment community will be paying close attention to the earnings performance of Cava Group in its upcoming release. The company is slated to reveal its earnings on August 11, 2026. The company is predicted to post an EPS of $0.17, indicating a 6.25% growth compared to the equivalent quarter last year. Alongside, our most recent consensus estimate is anticipating revenue of $353.13 million, indicating a 25.84% upward movement from the same quarter last year.

For the full year, the Zacks Consensus Estimates are projecting earnings of $0.54 per share and revenue of $1.49 billion, which would represent changes of 0% and +26.17%, respectively, from the prior year.

Any recent changes to analyst estimates for Cava Group should also be noted by investors. These revisions typically reflect the latest short-term business trends, which can change frequently. As such, positive estimate revisions reflect analyst optimism about the business and profitability.

Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.

The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has shifted 0.37% downward. At present, Cava Group boasts a Zacks Rank of #3 (Hold).

In terms of valuation, Cava Group is presently being traded at a Forward P/E ratio of 114.82. This expresses a premium compared to the average Forward P/E of 20.11 of its industry.

We can additionally observe that CAVA currently boasts a PEG ratio of 4.29. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. Retail - Restaurants stocks are, on average, holding a PEG ratio of 1.96 based on yesterday's closing prices.

The Retail - Restaurants industry is part of the Retail-Wholesale sector. This group has a Zacks Industry Rank of 209, putting it in the bottom 16% of all 250+ industries.

The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.

Ondo Finance’s ONDO token has drawn renewed interest from the market following a breakout supported by rising adoption of real-world assets (RWA) and the introduction of tokenized stock collateral for perpetual trading. The new feature, allowing traders to use tokenized equities as collateral, has added momentum to ONDO’s price recovery as traders monitor whether the token can approach the $0.50 resistance zone.

Ondo Finance expands with tokenized collateralFounded as a decentralized platform for tokenizing financial assets, Ondo Finance develops products that bring traditional financial instruments onto the blockchain. The company’s latest integration enables traders to leverage tokenized stocks as collateral for perpetual contracts, which supporters say could boost accessibility and liquidity in Ondo’s growing RWA ecosystem.

Following the announcement, ONDO had already rallied above a bullish pennant formation, indicating that traders were anticipating further upside. Technical analysis showed ONDO trading above its 20-day Simple Moving Average, suggesting a positive short-term trend.

Market data indicated a price recovery to the $0.40 region with capitalization staying above $1.7 billion. Buyers defending this area set the stage for a possible attempt at breaking through the key $0.50 barrier.

ONDO’s rally strengthened after the launch of tokenized stock collateral for perpetual trading, adding new use cases to the RWA ecosystem and supporting the token’s attempt to reclaim higher resistance levels.

Mini dictionary: Real-world assets (RWA) are traditional assets such as bonds, stocks, or property, represented in digital form on blockchain networks to enable new forms of access and trading.

2026 ONDO price scenarios and technical targetsONDO’s outlook for 2026 depends on multiple factors, including broader RWA demand, Bitcoin’s market trend, and institutional adoption. Analysts point to several scenarios that could play out depending on support and resistance levels:

ScenarioPrice TargetConditionsBearish$0.28 – $0.32Breakout fails, weak crypto sentimentBase Case$0.45 – $0.55Steady RWA growth, gradual buyingBullish$0.70 – $1.00Strong institutional adoption, broader market rallyThe first major resistance zone is $0.45, followed by the psychological $0.50 level. Breaking above these points may indicate further upward potential, but analysts emphasize that technical strength alone will not be enough unless RWA adoption continues growing.

Returning to previous all-time highs would require a significant increase in demand and valuation, and progress will likely depend on how effectively Ondo Finance can drive institutional use of its products.

Whale activity and investor positioningIn addition to technical data, activity from large holders (“whales”) has increased following ONDO’s breakout, pointing to growing positions by long-term investors. Whale accumulation traditionally signals confidence in the project’s future growth prospects, especially when linked to infrastructure that bridges conventional finance and blockchain technology.

Unlike purely speculative assets, ONDO is backed by efforts to enable blockchain-based settlement and ownership of real-world financial assets. As financial institutions seek new blockchain solutions for securities, Ondo’s offerings have aligned with one of the sector’s fastest-growing trends.

Analysts still caution that accumulation trends alone do not guarantee price increases. Market corrections are possible if sentiment turns or traders sell near resistance zones.

Mini dictionary: Ondo Finance is a platform that turns real-world financial products like securities and bonds into blockchain-based assets to create new investment opportunities.

Outlook for the $1 targetA move toward $1 by 2026 remains an ambitious scenario, as ONDO’s market capitalization would need to rise sharply. Reaching that milestone would likely require growing adoption of Ondo’s tokenized finance products and broader participation from institutional investors, combined with favorable overall market conditions.

The $0.50 area is currently seen as the most realistic near-term milestone for ONDO, while the $1 target represents a longer-term, bullish case that assumes substantial growth in the RWA market.

Competition in tokenized assets is accelerating and regulatory risks remain factors for investors to watch. Price rallies triggered by new product launches can fade if adoption is slower than expected, making ongoing monitoring of support and resistance zones essential.

Disclaimer: The information contained in this article does not constitute investment advice. Investors should be aware that cryptocurrencies carry high volatility and therefore risk, and should conduct their own research.

The court blocked the companies from closing the acquisition through mid-August, as a judge considers two lawsuits challenging it.

Gold price (XAU/USD) faces some selling pressure to around $4,050 during the early Asian session on Friday. The precious metal retreats from a two-month high as rising tensions in the Middle East war lift oil prices, hardening bets that the US Federal Reserve (Fed) will resume raising interest rates as soon as next week.

Yemen’s Tehran-backed Houthi militant group said its forces attacked two Saudi oil tankers in the Red Sea that had "violated" its blockade of Saudi ports, as the US carried out a 13th consecutive night of strikes on Iran. This development has fueled concerns about wider conflict in the Middle East. 

Additionally, US President Donald Trump warned the Houthis on Thursday that if they did so again, the US would inflict "major military punishment" upon both them and Iran. Trump further stated that he’s “considering a massive attack” on Iran, per Axios. He told the news outlet that it would be “bigger than ever before,” before adding, “I am close to making a decision. We are all set for it.” 

A crude oil-led inflation scare amid the Iran war boosts Fed rate hike bets, which could undermine the non-yielding asset such as the yellow metal in the near term. Money markets are now pricing in nearly a 35.8% chance of a rate hike from the Fed this month, as well as an 82.1% probability of at least a quarter-point hike in September, per CME’s FedWatch tool.

Gold FAQs Gold has played a key role in human’s history as it has been widely used as a store of value and medium of exchange. Currently, apart from its shine and usage for jewelry, the precious metal is widely seen as a safe-haven asset, meaning that it is considered a good investment during turbulent times. Gold is also widely seen as a hedge against inflation and against depreciating currencies as it doesn’t rely on any specific issuer or government.

Central banks are the biggest Gold holders. In their aim to support their currencies in turbulent times, central banks tend to diversify their reserves and buy Gold to improve the perceived strength of the economy and the currency. High Gold reserves can be a source of trust for a country’s solvency. Central banks added 1,136 tonnes of Gold worth around $70 billion to their reserves in 2022, according to data from the World Gold Council. This is the highest yearly purchase since records began. Central banks from emerging economies such as China, India and Turkey are quickly increasing their Gold reserves.

Gold has an inverse correlation with the US Dollar and US Treasuries, which are both major reserve and safe-haven assets. When the Dollar depreciates, Gold tends to rise, enabling investors and central banks to diversify their assets in turbulent times. Gold is also inversely correlated with risk assets. A rally in the stock market tends to weaken Gold price, while sell-offs in riskier markets tend to favor the precious metal.

The price can move due to a wide range of factors. Geopolitical instability or fears of a deep recession can quickly make Gold price escalate due to its safe-haven status. As a yield-less asset, Gold tends to rise with lower interest rates, while higher cost of money usually weighs down on the yellow metal. Still, most moves depend on how the US Dollar (USD) behaves as the asset is priced in dollars (XAU/USD). A strong Dollar tends to keep the price of Gold controlled, whereas a weaker Dollar is likely to push Gold prices up.

Apple Inc. is preparing to debut new versions of every Mac it sells, across this fall and next year, seeking to capitalize on demand for powerful laptops and desktops fueled by the artificial intelligence boom. Mark Gurman reports on "Bloomberg Tech.

Slipping 2.15% to 25,138, the Nasdaq Composite (^IXIC -2.15%) dropped sharply today, driven by a broad retreat in technology stocks following earnings reports. The S&P 500 (^GSPC -1.21%) lost 1.21% to 7,408 and the Dow Jones Industrial Average (^DJI -0.97%) fell 0.97% to 51,712.

Index

S&P 500 IndexToday's Change

(

-1.21

%)

-90.66

Index Level

7,408.30

Gold prices fell 2.36% to $4,048.76 as of U.S. market close, and the 10-Year Treasury yield rose 0.04% to 4.67%, a 52-week high. Communication services and consumer cyclicals were the biggest losers today, while industrials and healthcare stocks showed strength.

Today's biggest movesAlphabet fell by 7%, and Tesla shares tumbled almost 15% following yesterday’s earnings. In contrast, Intel rose in after-hours trading following its Q2 results, which beat expectations. EquipmentShare.com rose 8%, extending gains after increasing its revenue guidance earlier this month.

What this means for investorsThe risk that the huge outlays on artificial intelligence (AI) infrastructure might not pay off pressured technology stocks today. Rising oil prices and high Treasury yields compounded the risk-off mood. WTI crude oil gained 5.8% to $91.84 a barrel on reports that Houthi militia had attacked tankers in the Red Sea, threatening an alternative supply route to the Strait of Hormuz, which remains largely closed.

Mounting concern over heavy AI capital expenditures hit both Alphabet and Tesla shares. Increased spending from both firms — without a clear indication of when investors will see returns — weighed on shares. Investors are shifting their stances on AI spending sprees, which could justify a more cautious stance on big tech firms.

Emma Newbery has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Alphabet, Intel, and Tesla. The Motley Fool has a disclosure policy.

HomeEarnings AnalysisConsumer 

SummaryTesla, Inc. and CEO Elon Musk appear to be deprioritizing the robotaxi initiative.Momentum in TSLA's robotaxi business has stalled, raising doubts about near-term commercialization.This shift may impact TSLA's growth narrative and valuation tied to autonomous driving.Investors should reassess expectations for robotaxi-driven upside in TSLA's investment thesis. Naypong/iStock via Getty Images

Elon Musk and Tesla, Inc. (TSLA) seem to be losing interest in its robotaxi business, as it appears to have stalled.

Ignoring His Previous Promises So much has changed in a year. A year ago, Elon Musk

4.64K Followers

Analyst’s Disclosure: I/we have a beneficial short position in the shares of TSLA either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

In the latest close session, Coca-Cola (KO - Free Report) was down 1.25% at $81.17. This change lagged the S&P 500's 1.21% loss on the day. Meanwhile, the Dow lost 0.97%, and the Nasdaq, a tech-heavy index, lost 2.15%.

Shares of the world's largest beverage maker witnessed a gain of 1.99% over the previous month, trailing the performance of the Consumer Staples sector with its gain of 3.66%, and outperforming the S&P 500's gain of 0.42%.

Market participants will be closely following the financial results of Coca-Cola in its upcoming release. The company plans to announce its earnings on July 28, 2026. The company is predicted to post an EPS of $0.92, indicating a 5.75% growth compared to the equivalent quarter last year. Meanwhile, the latest consensus estimate predicts the revenue to be $13.05 billion, indicating a 4.15% increase compared to the same quarter of the previous year.

KO's full-year Zacks Consensus Estimates are calling for earnings of $3.26 per share and revenue of $49.24 billion. These results would represent year-over-year changes of +8.67% and +2.81%, respectively.

It is also important to note the recent changes to analyst estimates for Coca-Cola. Such recent modifications usually signify the changing landscape of near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the business outlook.

Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.

The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 0.08% lower within the past month. Currently, Coca-Cola is carrying a Zacks Rank of #3 (Hold).

Looking at its valuation, Coca-Cola is holding a Forward P/E ratio of 25.22. This indicates a premium in contrast to its industry's Forward P/E of 20.58.

Meanwhile, KO's PEG ratio is currently 3.33. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. KO's industry had an average PEG ratio of 2.18 as of yesterday's close.

The Beverages - Soft drinks industry is part of the Consumer Staples sector. Currently, this industry holds a Zacks Industry Rank of 69, positioning it in the top 29% of all 250+ industries.

The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Keep in mind to rely on Zacks.com to watch all these stock-impacting metrics, and more, in the succeeding trading sessions.

SpaceX's list of shareholders includes a who's who of big tech companies.

1.02K Followers

Analyst’s Disclosure: I/we have a beneficial long position in the shares of GOOG either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Amazon (AMZN -4.57%) and Microsoft (MSFT -2.13%) are the two biggest names in cloud computing. Their computing platforms have attracted a ton of new clients and are expanding their agreements with many established ones. This is leading to soaring revenue growth for both companies, but which one makes for the better investment now?

Image source: Getty Images.

Each company is widely diversified Both Amazon and Microsoft have legacy businesses that have gotten them to this point, but cloud computing may be what takes them into the future. Amazon is the biggest name in e-commerce and has built an impressive reputation for its wide product selection, rapid delivery, and fair prices. This created a strong base business that allowed it to rapidly expand its cloud computing footprint, and led to it becoming the world's top cloud infrastructure provider. One interesting thing to note is that Amazon Web Services (AWS), its cloud computing platform, actually generates more operating profits than its commerce divisions, accounting for 59% of the bottom line during Q1. One could consider AWS to be Amazon's primary business, especially when the company is spending $200 billion on data center capital expenditures this year.

Today's Change

(

-4.57

%) $

-11.19

Current Price

$

233.66

Microsoft is mostly a software company, and it gets a ton of revenue from its business productivity software. However, its cloud segment, Azure, is becoming an increasingly larger part of its business. Microsoft doesn't publicly break out the individual operating characteristics of each segment, so investors can't know precisely how profitable Azure is. But we know that it's growing at a 40% clip -- faster than AWS' 28% pace. Still, AWS is a larger service than Azure, which could account for that growth mismatch.

Today's Change

(

-2.13

%) $

-8.31

Current Price

$

382.03

These companies' core businesses are highly regarded and pretty safe. It would be splitting hairs to declare a winner here, so I'm calling it a tie.

Winner: Tie

Similar growth rates During their most recently reported quarters, Amazon's overall revenue rose at a 17% pace, while Microsoft's grew at an 18% clip. That tracks with a historical trend of Microsoft growing ever so slightly faster than Amazon. However, that's only from a revenue growth standpoint.

AMZN Revenue (Quarterly YoY Growth) data by YCharts

Both have made significant investments and had one-time events that have affected their earnings per share, making it a harder metric to analyze. However, operating cash flow gives investors a good measure of a company's profit growth potential, and Amazon has jumped ahead of Microsoft in that category as of late.

AMZN Cash from Operations (Quarterly YoY Growth) data by YCharts.

At the end of the day, these two are remarkably close from a growth standpoint, so I have to call this category another tie.

Winner: Tie

Will valuation break the tie? This whole comparison cannot end in a tie, so I'm looking at valuation to determine a final winner. Fortunately, there's a clear winner here.

For some time, Amazon and Microsoft traded within similar valuation ranges. However, they've diverged throughout 2026.

AMZN PE Ratio (Forward) data by YCharts.

Microsoft has fallen well below its normal trading range, making it much cheaper than Amazon. Considering how close in performance these two are from a financial standpoint, I think that Microsoft's lower valuation of 20.5 times forward earnings makes it a better buy. That's a ridiculously low price to pay for the stock, especially considering that the S&P 500 (^GSPC -1.21%) trades for 21.5 times forward earnings.

I'm still bullish on Amazon's stock, too, but Microsoft is the better buy right now.

Winner: Microsoft

Nvidia (NVDA -1.56%) has been one of the best stocks to own over the past few years. However, so far in 2026, it has been just an average performer: It's essentially even with the S&P 500's (^GSPC -1.21%) gains year-to-date.

That tepid stock performance is out of step with its business results, as it has been crushing it lately. In fact, Nvidia's underperformance this year has actually caused its valuation to dip to its lowest point since 2019. That's why I believe the stock is one of the best buys in the market right now.

Image source: The Motley Fool.

AI wasn't in focus the last time Nvidia was this cheap On a trailing price-to-earnings (P/E) basis, Nvidia is trading at a ratio of about 31. The last time Nvidia's stock traded for about 30 times earnings was in 2019.

NVDA PE Ratio data by YCharts.

Nvidia's stock certainly has a long way to go before reaching the lows it hit that year again, but what's more notable is that Nvidia is now cheaper than it has been during any other time in the AI infrastructure build-out, which started in 2023. That's significant, because its outlook is quite strong.

For this fiscal year, Wall Street analysts expect Nvidia to deliver 82% revenue growth, and next year, they expect 42%. Those are still excellent results, and the reality is that the analysts are likely underestimating next year's growth, as Wall Street has consistently underprojected Nvidia's results.

Today's Change

(

-1.56

%) $

-3.31

Current Price

$

208.75

The AI build-out is still gaining momentum, and that bodes well for the chipmaker's future. So, paying 31 times earnings for Nvidia seems like a smart move, especially when its big tech peers trade at similar or higher levels, with lower growth expectations. Apple (AAPL -1.30%) and Alphabet (GOOG -6.88%)(GOOGL -7.12%) trade for 40 and 27 times earnings, respectively. Both of these companies are lucky to grow their revenue at a 20% pace, let alone the nearly 100% growth Wall Street expects from Nvidia during Q2.

If you compare Nvidia to chip industry peers like AMD (AMD -2.31%) and Broadcom (AVGO -1.19%), these two trade for 165 and 63 times earnings, respectively. Yet Nvidia is growing at a faster pace than either of them.

NVDA Revenue (Quarterly YoY Growth) data by YCharts.

Nvidia is delivering incredible growth, and few companies can match it. With Nvidia trading at around the same (or cheaper) valuations as many of them, this valuation gap will widen even more. As a result, I think Nvidia is a fantastic buy, as the market isn't respecting Nvidia like it once did. Eventually, it will come back around, and when it does, Nvidia will be the best stock to own in the market once again.

Keithen Drury has positions in Alphabet, Broadcom, and Nvidia. The Motley Fool has positions in and recommends Advanced Micro Devices, Alphabet, Apple, Broadcom, and Nvidia. The Motley Fool has a disclosure policy.